+ More Filters

Reset Filters

Title

Funding Organization

Funding Type

Eligible Country

Deadline

Other (Select all that apply)

Show Expired Programs

Show Verified Programs

Not Verified

Young Investigator Awards for outstanding publication

European Atherosclerosis Society

The call for nominations will open December 1, 2025 until February 2, 2026.
Results will be announced in March 2026.

The annual EAS Young Investigator Awards for outstanding publications, recognize distinction that contributes to the advancement of knowledge in the field of atherosclerosis or atherosclerosis and metabolic disturbances.

Two recipients (one in basic science and one in clinical research) will each receive a prize of €2000. The award ceremony will take place during the Opening Ceremony of the EAS Congress.

The winners will also be invited to present their research during the Congress on the EAS Stage.

Review and selection process

Nominations will be reviewed by the Society’s Award Committee.
The Society’s Executive Committee will make the final selection of Award recipients.

Announcement

Results will be announced by the end of March.

AI Based Application Success Predictor

Because EAS offers multiple funding types with slightly different focus areas, the success predictors vary by type — but several common themes emerge across schemes:

🎓 1. Strong Scientific Merit and Relevance to Atherosclerosis

Whether applying for project support, a fellowship, or an award, your work must be clearly rooted in atherosclerosis biology, pathophysiology, clinical outcomes, cardiovascular risk, lipid metabolism, or related metabolic disturbances.

For publication-based awards (e.g., Young Investigator Awards), the scientific advance of the paper itself matters. EAS

For project support, your research hypothesis and aims should target gaps in atherosclerosis knowledge or implementation. EAS

Success tip: Explicitly frame your research questions within the broader context of cardiovascular and metabolic disease impact.

🧪 2. Competitive Abstract and Presentation Quality

For fellowship and travel grants tied to the EAS Congress, selection is competitive and strongly influenced by the quality of your submitted abstract and the scientific soundness of your presentation.

Ensure your abstract is clear, hypothesis-driven (vs. descriptive), and uses rigorous methods. EAS

Success tip: Draft and revise your abstract to emphasize novelty, methodological rigor, and relevance to the meeting theme.

👩‍🔬 3. Early Career Status and Career Trajectory

Many EAS grants support early‐career investigators (e.g., ≤ 35 yrs for fellowships), so demonstrating your commitment to atherosclerosis research, signs of independence, and potential to become a leader in the field strengthens your application. EAS

Success predictors include:

Evidence of first-author publications

Past participation in scientific meetings

Clear description of career goals related to atherosclerosis

📈 4. EAS Membership and Engagement

Active involvement with EAS (membership, attending Congress, participating in committees, or workshops) signals commitment and enhances eligibility for many awards and travel grants. Facebook

Success predictor: Maintain up-to-date membership and engage in society activities before applying.

🤝 5. Clear Case for Impact and Mentoring Potential

For project or early-career funding:

Present a lucid explanation of how your project will progress the field. EAS

When applicable, describe mentorship and how the funding will help you build research independence.

Success tip: Include measurable aims, timelines, and indicators of success.

🌍 6. Travel and Financial Need (for Travel Grants)

For educational travel grants, applications that demonstrate financial need or barriers to attendance (especially from low-resource countries) are competitive — as these schemes are designed to enhance inclusion. EAS

Success predictor: Provide succinct but persuasive justification of financial need.

📝 7. Publication Record for Award Nominations

For awards like the Young Investigator Awards, the impact of your publications (e.g., journals, citation influence, novelty of findings) is paramount. EAS

Success tip: Choose your strongest, newly published work for nomination and emphasize its advancement of atherosclerosis science.

🧠 Practical, Scheme-Specific Tips

💡 For Competitive Early Career Research Grants

Confirm you meet eligibility criteria (often early career / member status). EAS

Provide a clear research plan with hypotheses, methods, and expected impact.

Tailor the application to show how the funds will enable a specific milestone in early atherosclerosis research.

🎤 For Young Investigator Fellowships & Travel Grants

Submit your abstract early and polish it for clarity and scientific relevance. EAS

Highlight why attending the Congress benefits your career and scientific development.

🏆 For Awards (e.g., Young Investigator or Anitschkow Prize)

Nominate work that’s both high-impact and recent. EAS

Clearly articulate the scientific advance and relevance to the atherosclerosis/metabolic field.

🧠 Summary of Success Predictors

Success Predictor	Why It Matters
Aligns with atherosclerosis research focus	Core mission of EAS
Membership + active engagement	Eligibility and reviewer perception Facebook
Strong, hypothesis-driven abstract+methods	Key for fellowships and travel support EAS
Early career evidence & potential	Target group for many EAS schemes EAS
Clear impact & career narrative	Helps reviewers assess significance
Publication impact (for awards)	Reflects scientific excellence EAS
Financial need (for travel awards)	Meets target criteria

Specialties

Cancer

Neurosciences

Eligibility Requirements

Article eligibility

The nominated article should have been published January 01 – December 31.
The article should be in English.
The nominated article should be an original research article.

Nominee eligibility

The Nominee must be the first author of the nominated paper.
Only one nominee is allowed per paper.
The Nominee must be 40 years or younger on December 31, the year of publication (ID evidence compulsory with nomination).
EAS membership not required for the Nominee.

Nomination requirements

Nominations must be submitted by an active *EAS Individual member or EAS Student member (i.e. who has paid their annual membership subscription for the year of publication).
Self-nominations are allowed.
The nomination must be submitted using the official nomination form (accessible to EAS Individual members & EAS Student members only)*.

Sponsor Details

Sponsor Institute/Organizations: European Atherosclerosis Society

Sponsor Type: Corporate/Non-Profit

Address: Första Långgatan 4A 413 03 Göteborg

Legal & Affiliation Disclaimer

Affiliation Disclaimer: Trialect operates independently and is not affiliated with, endorsed by, or supported by any sponsors or organizations posting on the GrantsBoard platform. As an independent aggregator of publicly available funding opportunities, Trialect provides equal access to information for all users without endorsing any specific funding source, content, organization, or sponsor. Trialect assumes no responsibility for the content posted by sponsors or third parties.

Subscription Disclaimer: Upon logging into Trialect, you may choose to SUBSCRIBE to GrantsBoard for timely notifications of funding opportunities and to access exclusive benefits, such as priority alerts, reminders, personalized recommendations, and additional application support. However, users are advised to contact sponsors directly for any questions and are not required to subscribe to engage with funding opportunities.

Content Ownership and Copyright Disclaimer: Trialect respects the intellectual property rights of all organizations and individuals. All content posted on GrantsBoard is provided solely for informational purposes and remains the property of the original owners. Trialect does not claim ownership of, nor does it have any proprietary interest in, content provided by third-party sponsors. Users are encouraged to verify content and ownership directly with the posting sponsor.

Fair Use Disclaimer: The information and content available on GrantsBoard are compiled from publicly accessible sources in alignment with fair use principles under U.S. copyright law. Trialect serves as an aggregator of this content, offering it to users in good faith and with the understanding that it is available for public dissemination. Any organization or individual who believes their intellectual property rights have been violated is encouraged to contact us for prompt resolution.

Third-Party Posting Responsibility Disclaimer: Trialect is a neutral platform that allows third-party sponsors to post funding opportunities for informational purposes only. Sponsors are solely responsible for ensuring that their postings comply with copyright, trademark, and other intellectual property laws. Trialect assumes no liability for any copyright or intellectual property infringements in third-party content and will take appropriate action to address any substantiated claims.

Accuracy and Verification Disclaimer: Trialect makes no warranties regarding the accuracy, completeness, or reliability of the information provided by sponsors. Users are advised to verify the details of any funding opportunity directly with the sponsor before taking action. Trialect cannot be held liable for any discrepancies, omissions, or inaccuracies in third-party postings.

Notice and Takedown Policy: Trialect is committed to upholding copyright law and protecting the rights of intellectual property owners. If you believe that content on GrantsBoard infringes your copyright or intellectual property rights, please contact us with detailed information about the claim. Upon receipt of a valid notice, Trialect will promptly investigate and, where appropriate, remove or disable access to the infringing content.

View Funding Opportunity